Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduction of Alzheimer’s Disease Amyloid Plaque Load in Transgenic Mice by D3, a <scp>D</scp> ‐Enantiomeric Peptide Identified by Mirror Image Phage Display

17 Nov 2008

Abstract excerpt

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, affecting more than 20 million people world-wide. Only palliative therapies are available today. We identified a novel D-enantiomeric amino acid peptide “D3” with significant Aβ disaggregation and Aβ aggregation inhibiting properties in vitro an in vivo. It inhibits cytotoxicity in cell culture and reduces amyloid plaque load and cerebral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amino Acid Enzymes and Metabolism
Share to Chemical Synthesis and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19016284
DOI: 10.1002/cmdc.200800273

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduction of Alzheimer’s Disease Amyloid Plaque Load in Transgenic Mice by D3, a <scp>D</scp> ‐Enantiomeric Peptide Identified by Mirror Image Phage DisplayPMID 19016284Read ↗

Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.Semantic proximity Read ↗

Oral Treatment with the <scp>d</scp>-Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer’s Disease Transgenic MiceSemantic proximity Read ↗

Differently Selected <scp>d</scp> -Enantiomeric Peptides Act on Different Aβ SpeciesSemantic proximity Read ↗

Phage display derived peptides for Alzheimer's disease therapy and diagnosisSemantic proximity Read ↗

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

Direct disassembly of α-syn preformed fibrils into native α-syn monomers by an all-D-peptideSemantic proximity Read ↗

Aβ oligomer eliminating compounds interfere successfully with pEAβ(3-42) induced motor neurodegenerative phenotype in transgenic mice.Semantic proximity Read ↗

In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42‐Binding <scp>D</scp>‐Enantiomeric Peptides in Transgenic AD Mouse ModelsSemantic proximity Read ↗

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitroSemantic proximity Read ↗

Synergistic Screening of Peptide-Based Biotechnological Drug Candidates for Neurodegenerative Diseases using Yeast Display and Phage DisplaySemantic proximity Read ↗

Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defectsSemantic proximity Read ↗

Domino-like Effect of C112R Mutation on ApoE4 Aggregation and Its Reduction by Alzheimer’s Disease Drug CandidateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.